Protein name:
Sodium channel protein type 9 subunit alpha ;
Alternative:
Peripheral sodium channel 1 (PN1) ;Neuroendocrine sodium channel (hNE-Na) ;Voltage-gated sodium channel subunit alpha Nav1.7 ;Sodium channel protein type IX subunit alpha ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
The sodium channel consists of a large polypeptide and 2-3 smaller ones. This sequence represents a large polypeptide. Interacts with NEDD4 and NEDD4L.
Function:
Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient. It is a tetrodotoxin-sensitive Na(+) channel isoform. Plays a role in pain mechanisms, especially in the development of inflammatory pain.
Subcellular Location:
Membrane
Multi-pass membrane protein
In neurite terminals.
Protein Attributes:
50:
MAMLPPPGPQ | SFVHFTKQSL | ALIEQRIAER | KSKEPKEEKK | DDDEEAPKPS |
100:
SDLEAGKQLP | FIYGDIPPGM | VSEPLEDLDP | YYADKKTFIV | LNKGKTIFRF |
150:
NATPALYMLS | PFSPLRRISI | KILVHSLFSM | LIMCTILTNC | IFMTMNNPPD |
200:
WTKNVEYTFT | GIYTFESLVK | ILARGFCVGE | FTFLRDPWNW | LDFVVIVFAY |
250:
LTEFVNLGNV | SALRTFRVLR | ALKTISVIPG | LKTIVGALIQ | SVKKLSDVMI |
300:
LTVFCLSVFA | LIGLQLFMGN | LKHKCFRNSL | ENNETLESIM | NTLESEEDFR |
350:
KYFYYLEGSK | DALLCGFSTD | SGQCPEGYTC | VKIGRNPDYG | YTSFDTFSWA |
400:
FLALFRLMTQ | DYWENLYQQT | LRAAGKTYMI | FFVVVIFLGS | FYLINLILAV |
450:
VAMAYEEQNQ | ANIEEAKQKE | LEFQQMLDRL | KKEQEEAEAI | AAAAAEYTSI |
500:
RRSRIMGLSE | SSSETSKLSS | KSAKERRNRR | KKKNQKKLSS | GEEKGDAEKL |
550:
SKSESEDSIR | RKSFHLGVEG | HRRAHEKRLS | TPNQSPLSIR | GSLFSARRSS |
600:
RTSLFSFKGR | GRDIGSETEF | ADDEHSIFGD | NESRRGSLFV | PHRPQERRSS |
650:
NISQASRSPP | MLPVNGKMHS | AVDCNGVVSL | VDGRSALMLP | NGQLLPEVII |
700:
DKATSDDSGT | TNQIHKKRRC | SSYLLSEDML | NDPNLRQRAM | SRASILTNTV |
750:
EELEESRQKC | PPWWYRFAHK | FLIWNCSPYW | IKFKKCIYFI | VMDPFVDLAI |
800:
TICIVLNTLF | MAMEHHPMTE | EFKNVLAIGN | LVFTGIFAAE | MVLKLIAMDP |
850:
YEYFQVGWNI | FDSLIVTLSL | VELFLADVEG | LSVLRSFRLL | RVFKLAKSWP |
900:
TLNMLIKIIG | NSVGALGNLT | LVLAIIVFIF | AVVGMQLFGK | SYKECVCKIN |
950:
DDCTLPRWHM | NDFFHSFLIV | FRVLCGEWIE | TMWDCMEVAG | QAMCLIVYMM |
1000:
VMVIGNLVVL | NLFLALLLSS | FSSDNLTAIE | EDPDANNLQI | AVTRIKKGIN |
1050:
YVKQTLREFI | LKAFSKKPKI | SREIRQAEDL | NTKKENYISN | HTLAEMSKGH |
1100:
NFLKEKDKIS | GFGSSVDKHL | MEDSDGQSFI | HNPSLTVTVP | IAPGESDLEN |
1150:
MNAEELSSDS | DSEYSKVRLN | RSSSSECSTV | DNPLPGEGEE | AEAEPMNSDE |
1200:
PEACFTDGCV | WRFSCCQVNI | ESGKGKIWWN | IRKTCYKIVE | HSWFESFIVL |
1250:
MILLSSGALA | FEDIYIERKK | TIKIILEYAD | KIFTYIFILE | MLLKWIAYGY |
1300:
KTYFTNAWCW | LDFLIVDVSL | VTLVANTLGY | SDLGPIKSLR | TLRALRPLRA |
1350:
LSRFEGMRVV | VNALIGAIPS | IMNVLLVCLI | FWLIFSIMGV | NLFAGKFYEC |
1400:
INTTDGSRFP | ASQVPNRSEC | FALMNVSQNV | RWKNLKVNFD | NVGLGYLSLL |
1450:
QVATFKGWTI | IMYAAVDSVN | VDKQPKYEYS | LYMYIYFVVF | IIFGSFFTLN |
1500:
LFIGVIIDNF | NQQKKKLGGQ | DIFMTEEQKK | YYNAMKKLGS | KKPQKPIPRP |
1550:
GNKIQGCIFD | LVTNQAFDIS | IMVLICLNMV | TMMVEKEGQS | QHMTEVLYWI |
1600:
NVVFIILFTG | ECVLKLISLR | HYYFTVGWNI | FDFVVVIISI | VGMFLADLIE |
1650:
TYFVSPTLFR | VIRLARIGRI | LRLVKGAKGI | RTLLFALMMS | LPALFNIGLL |
1700:
LFLVMFIYAI | FGMSNFAYVK | KEDGINDMFN | FETFGNSMIC | LFQITTSAGW |
1750:
DGLLAPILNS | KPPDCDPKKV | HPGSSVEGDC | GNPSVGIFYF | VSYIIISFLV |
1800:
VVNMYIAVIL | ENFSVATEES | TEPLSEDDFE | MFYEVWEKFD | PDATQFIEFS |
1850:
KLSDFAAALD | PPLLIAKPNK | VQLIAMDLPM | VSGDRIHCLD | ILFAFTKRVL |
1900:
GESGEMDSLR | SQMEERFMSA | NPSKVSYEPI | TTTLKRKQED | VSATVIQRAY |
1950:
RRYRLRQNVK | NISSIYIKDG | DRDDDLLNKK | DMAFDNVNEN | SSPEKTDATS |
1988:
STTSPPSYDS | VTKPDKEKYE | QDRTEKEDKG | KDSKESKK
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Rabbit
Mouse
Rat
ELISA Kit for Human Sodium channel protein type 9 subunit alpha
ELISA Kit for Human Sodium channel protein type 9 subunit alpha
ELISA Kit for Human Sodium channel protein type 9 subunit alpha
ELISA Kit for Human Sodium channel protein type 9 subunit alpha
CLIA Kit for Human Sodium channel protein type 9 subunit alpha
CLIA Kit for Human Sodium channel protein type 9 subunit alpha
CLIA Kit for Human Sodium channel protein type 9 subunit alpha
CLIA Kit for Human Sodium channel protein type 9 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Polyclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Monoclonal Antibody for Human Sodium channel protein type 9 subunit alpha
Protein for Human Sodium channel protein type 9 subunit alpha
Protein for Human Sodium channel protein type 9 subunit alpha
Protein for Human Sodium channel protein type 9 subunit alpha
Protein for Human Sodium channel protein type 9 subunit alpha
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3);FUNCTION IN VOLTAGE-EVOKED DEPOLARIZATION;TISSUE SPECIFICITY;VARIANT ARG-1161
tissue :
Thyroid .
2.
"An SCN9A channelopathy causes congenital inability to experience pain."
Cox J.J.
,
Reimann F.
,
Nicholas A.K.
,
Thornton G.
,
Roberts E.
,
Springell K.
,
Karbani G.
,
Jafri H.
,
Mannan J.
,
Raashid Y.
,
Al-Gazali L.
,
Hamamy H.
,
Valente E.M.
,
Gorman S.
,
Williams R.
,
McHale D.P.
,
Wood J.N.
,
Gribble F.M.
,
Woods C.G.
more...
Nature444:894-898(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3);INVOLVEMENT IN CONGENITAL INSENSITIVITY TO PAIN;CHARACTERIZATION;VARIANT ARG-1161
3.
"Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
Hillier L.W.
,
Graves T.A.
,
Fulton R.S.
,
Fulton L.A.
,
Pepin K.H.
,
Minx P.
,
Wagner-McPherson C.
,
Layman D.
,
Wylie K.
,
Sekhon M.
,
Becker M.C.
,
Fewell G.A.
,
Delehaunty K.D.
,
Miner T.L.
,
Nash W.E.
,
Kremitzki C.
,
Oddy L.
,
Du H.
,
Sun H.
,
Bradshaw-Cordum H.
,
Ali J.
,
Carter J.
,
Cordes M.
,
Harris A.
,
Isak A.
,
van Brunt A.
,
Nguyen C.
,
Du F.
,
Courtney L.
,
Kalicki J.
,
Ozersky P.
,
Abbott S.
,
Armstrong J.
,
Belter E.A.
,
Caruso L.
,
Cedroni M.
,
Cotton M.
,
Davidson T.
,
Desai A.
,
Elliott G.
,
Erb T.
,
Fronick C.
,
Gaige T.
,
Haakenson W.
,
Haglund K.
,
Holmes A.
,
Harkins R.
,
Kim K.
,
Kruchowski S.S.
,
Strong C.M.
,
Grewal N.
,
Goyea E.
,
Hou S.
,
Levy A.
,
Martinka S.
,
Mead K.
,
McLellan M.D.
,
Meyer R.
,
Randall-Maher J.
,
Tomlinson C.
,
Dauphin-Kohlberg S.
,
Kozlowicz-Reilly A.
,
Shah N.
,
Swearengen-Shahid S.
,
Snider J.
,
Strong J.T.
,
Thompson J.
,
Yoakum M.
,
Leonard S.
,
Pearman C.
,
Trani L.
,
Radionenko M.
,
Waligorski J.E.
,
Wang C.
,
Rock S.M.
,
Tin-Wollam A.-M.
,
Maupin R.
,
Latreille P.
,
Wendl M.C.
,
Yang S.-P.
,
Pohl C.
,
Wallis J.W.
,
Spieth J.
,
Bieri T.A.
,
Berkowicz N.
,
Nelson J.O.
,
Osborne J.
,
Ding L.
,
Meyer R.
,
Sabo A.
,
Shotland Y.
,
Sinha P.
,
Wohldmann P.E.
,
Cook L.L.
,
Hickenbotham M.T.
,
Eldred J.
,
Williams D.
,
Jones T.A.
,
She X.
,
Ciccarelli F.D.
,
Izaurralde E.
,
Taylor J.
,
Schmutz J.
,
Myers R.M.
,
Cox D.R.
,
Huang X.
,
McPherson J.D.
,
Mardis E.R.
,
Clifton S.W.
,
Warren W.C.
,
Chinwalla A.T.
,
Eddy S.R.
,
Marra M.A.
,
Ovcharenko I.
,
Furey T.S.
,
Miller W.
,
Eichler E.E.
,
Bork P.
,
Suyama M.
,
Torrents D.
,
Waterston R.H.
,
Wilson R.K.
more...
Nature434:724-731(2005)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 136-674 (ISOFORMS 1; 2 AND 3);TISSUE SPECIFICITY
tissue :
Spinal ganglion .
5.
"Upregulation of voltage-gated Na+ channel expression and metastatic potential in human breast cancer: correlative studies on cell lines and biopsy tissues."
Diss J.K.J.
,
Fraser S.P.
,
Coombes R.C.
,
Djamgoz M.B.A.
Submitted (2001-04) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] OF 150-264 AND 1340-1400
6.
"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia."
Yang Y.
,
Wang Y.
,
Li S.
,
Xu Z.
,
Li H.
,
Ma L.
,
Fan J.
,
Bu D.
,
Liu B.
,
Fan Z.
,
Wu G.
,
Jin J.
,
Ding B.
,
Zhu X.
,
Shen Y.
J. Med. Genet.41:171-174(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 840-958;VARIANTS PERYTHM THR-859 AND HIS-869
7.
"A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia."
Sangameswaran L.
,
Fish L.M.
,
Koch B.D.
,
Rabert D.K.
,
Delgado S.G.
,
Ilnicka M.
,
Jakeman L.B.
,
Novakovic S.
,
Wong K.
,
Sze P.
,
Tzoumaka E.
,
Stewart G.R.
,
Herman R.C.
,
Chan H.
,
Eglen R.M.
,
Hunter J.C.
J. Biol. Chem.272:14805-14809(1997)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : TISSUE SPECIFICITY
8.
"Voltage-gated sodium channel expressed in cultured human smooth muscle cells: involvement of SCN9A."
Jo T.
,
Nagata T.
,
Iida H.
,
Imuta H.
,
Iwasawa K.
,
Ma J.
,
Hara K.
,
Omata M.
,
Nagai R.
,
Takizawa H.
,
Nagase T.
,
Nakajima T.
FEBS Lett.567:339-343(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION IN VOLTAGE-EVOKED DEPOLARIZATION;TISSUE SPECIFICITY
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANTS PERYTHM THR-859 AND HIS-869
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT PERYTHM THR-241
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT PERYTHM VAL-1460;CHARACTERIZATION OF VARIANT PERYTHM VAL-1460
12.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS PERYTHM SER-216; LYS-395; THR-859 AND PHE-869;VARIANT ARG-1161
13.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT PERYTHM PHE-869;CHARACTERIZATION OF VARIANT PERYTHM PHE-869
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANT PERYTHM SER-216
15.
"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes."
Fertleman C.R.
,
Baker M.D.
,
Parker K.A.
,
Moffatt S.
,
Elmslie F.V.
,
Abrahamsen B.
,
Ostman J.
,
Klugbauer N.
,
Wood J.N.
,
Gardiner R.M.
,
Rees M.
Neuron52:767-774(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS PEPD CYS-1007; PHE-1309; ASP-1309; PHE-1310; THR-1472; VAL-1473; ILE-1475 AND LYS-1638;CHARACTERIZATION OF VARIANTS PEPD THR-1472; ILE-1475 AND LYS-1638
16.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANT PERYTHM HIS-869
17.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT PERYTHM ARG-10;CHARACTERIZATION OF VARIANTS PERYTHM ARG-10 AND THR-859
18.
"A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome."
Singh N.A.
,
Pappas C.
,
Dahle E.J.
,
Claes L.R.
,
Pruess T.H.
,
De Jonghe P.
,
Thompson J.
,
Dixon M.
,
Gurnett C.
,
Peiffer A.
,
White H.S.
,
Filloux F.
,
Leppert M.F.
PLoS Genet.5:E1000649-E1000649(2009)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS GEFS+7 TYR-641 AND ARG-666;VARIANTS FEB3B VAL-62 AND GLN-149;VARIANTS MET-228; ASN-490; LYS-519; MET-695; TYR-710; VAL-750; PHE-1134; GLN-1171 AND VAL-1278
19.
"Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations."
Cox J.J.
,
Sheynin J.
,
Shorer Z.
,
Reimann F.
,
Nicholas A.K.
,
Zubovic L.
,
Baralle M.
,
Wraige E.
,
Manor E.
,
Levy J.
,
Woods C.G.
,
Parvari R.
Hum. Mutat.31:E1670-E1686(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CIPAR GLN-907 AND 1381-ARG--LEU-1385 DEL;CHARACTERIZATION OF VARIANTS CIPAR GLN-907 AND 1381-ARG--LEU-1385 DEL